Trial Profile
Artemether-lumefantrine versus Artesunate-amodiaquine for treatment of uncomplicated plasmodium falciparum malaria in pregnancy; A randomized control trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Artesunate/amodiaquine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- 01 Oct 2015 Status changed from active, no longer recruiting to completed, as per an article published in the International Journal of Gynaecology and Obstetrics
- 20 Dec 2013 New trial record